Literature DB >> 11866323

Acts of control in schizophrenia: dissociating the components of inhibition.

J C Badcock1, P T Michie, L Johnson, J Combrinck.   

Abstract

BACKGROUND: Inhibitory deficits have been frequently reported in schizophrenia. Such deficits are usually associated with activities of prefrontal cortex and related networks. An understanding of intentional inhibitory control requires knowledge of how actions are planned and initiated and the components involved in stopping these actions.
METHODS: Patients with schizophrenia, a psychosis comparison group and a healthy control group participated in a visual choice reaction time (go) task and attempted to inhibit their responses to the go task when an auditory 'stop' signal was heard.
RESULTS: Schizophrenia patients demonstrated significantly slower response execution but the estimated speed of inhibition was not significantly different from that of healthy controls. Both patient groups were impaired in their ability to inhibit a response across a range of stop-signal delays. The poorer performance of schizophrenia patients only was related to a difficulty in reliably triggering the inhibitory response.
CONCLUSIONS: Impaired response inhibition is not unique to schizophrenia. However, the nature of their problem is markedly different from that of other psychopathological groups. Possible neural mechanisms underpinning difficulties in triggering inhibitory responses and in the voluntary initiation of actions in schizophrenia are considered.

Entities:  

Mesh:

Year:  2002        PMID: 11866323     DOI: 10.1017/s0033291701005128

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  40 in total

1.  Fore-period effect and stop-signal reaction time.

Authors:  Chiang-Shan Ray Li; John H Krystal; Daniel H Mathalon
Journal:  Exp Brain Res       Date:  2005-11-15       Impact factor: 1.972

2.  Response inhibition and response monitoring in a saccadic countermanding task in schizophrenia.

Authors:  Katharine N Thakkar; Jeffrey D Schall; Leanne Boucher; Gordon D Logan; Sohee Park
Journal:  Biol Psychiatry       Date:  2010-10-23       Impact factor: 13.382

Review 3.  Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction.

Authors:  Chiang-shan Ray Li; Rajita Sinha
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

Review 4.  CNTRICS final task selection: executive control.

Authors:  Deanna M Barch; Todd S Braver; Cameron S Carter; Russell A Poldrack; Trevor W Robbins
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

5.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

6.  Effects of nicotine on attention and inhibitory control in healthy nonsmokers.

Authors:  Nicholas D Wignall; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

7.  Response inhibition and response monitoring in a saccadic double-step task in schizophrenia.

Authors:  Katharine N Thakkar; Jeffrey D Schall; Gordon D Logan; Sohee Park
Journal:  Brain Cogn       Date:  2015-03-10       Impact factor: 2.310

8.  Automatic and controlled response inhibition: associative learning in the go/no-go and stop-signal paradigms.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  J Exp Psychol Gen       Date:  2008-11

9.  Dopamine and inhibitory action control: evidence from spontaneous eye blink rates.

Authors:  Lorenza Serena Colzato; Wery P M van den Wildenberg; Nelleke C van Wouwe; Merel M Pannebakker; Bernhard Hommel
Journal:  Exp Brain Res       Date:  2009-05-31       Impact factor: 1.972

10.  Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype?

Authors:  S Morein-Zamir; N A Fineberg; T W Robbins; B J Sahakian
Journal:  Psychol Med       Date:  2009-07-02       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.